{"id":"W4389465400","doi":"10.1212/wnl.92.15_supplement.p3.2-031","title":"Reduction in 48-Week Confirmed Disability Progression After 5.5 Years of Ocrelizumab Treatment in Patients With Primary Progressive Multiple Sclerosis (P3.2-031)","year":2019,"lang":"en","type":"article","venue":"Neurology","topic":"Peripheral Neuropathies and Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Toronto","funders":"","keywords":"Ocrelizumab; Medicine; Multiple sclerosis; Pediatrics; Oncology; Internal medicine; Dermatology; Immunology; Rituximab","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001489392,0.0003750177,0.0007959491,0.0002425363,0.0002606316,0.0003555476,0.000298639,0.0004724888,0.001433568],"category_scores_gemma":[0.001492148,0.00009684878,0.0008766811,0.0001958044,0.000181402,0.0004197505,0.0002728522,0.000933887,0.0001957051],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003897718,"about_ca_system_score_gemma":0.0004210267,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001724447,"about_ca_topic_score_gemma":0.003578944,"domain_scores_codex":[0.9995591,0.0001586415,0.00003710301,0.0000686506,0.00007028524,0.0001061898],"domain_scores_gemma":[0.9991418,0.0001620892,0.0003291464,0.00004812651,0.00008169046,0.0002371618],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.4657956,0.01727539,0.1949937,0.001307144,0.003922309,0.0005321335,0.0005829664,0.002581236,0.02051311,0.0002121829,0.003608617,0.2886755],"study_design_scores_gemma":[0.01929685,0.2004331,0.7719089,0.0001235355,0.001254087,0.000369959,0.0001212173,0.001186049,0.003038208,0.0001321507,0.00209374,0.00004219115],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9965407,0.001942919,0.00007097884,0.00006921377,0.00002617803,0.00006113292,0.0002795187,0.00001750976,0.0009917985],"genre_scores_gemma":[0.9986807,0.0002441105,0.00008956529,0.00005934074,0.00002335995,0.00004694933,0.0002823111,0.00000151848,0.0005721973],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001724447,"threshold_uncertainty_score":0.007876694,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01085781988190639,"score_gpt":0.2306196629575331,"score_spread":0.2197618430756267,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}